16:55 EST Precision BioSciences (DTIL) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DTIL:
- Ten new option listings on November 5th
- Precision BioSciences Reports Q3 2025 Financial Results
- Positive Buy Rating for Precision BioSciences Driven by Promising Clinical Trial Data and Strategic Developments
- Morning Movers: Kenvue surges, Kimberly-Clark sinks after tie up
- Precision BioSciences reports Q3 EPS ($1.84), consensus ($2.21)